Attached files
file | filename |
---|---|
10-K - FORM 10-K - VIA Pharmaceuticals, Inc. | c98548e10vk.htm |
EX-4.8 - EXHIBIT 4.8 - VIA Pharmaceuticals, Inc. | c98548exv4w8.htm |
EX-4.6 - EXHIBIT 4.6 - VIA Pharmaceuticals, Inc. | c98548exv4w6.htm |
EX-4.5 - EXHIBIT 4.5 - VIA Pharmaceuticals, Inc. | c98548exv4w5.htm |
EX-32.1 - EXHIBIT 32.1 - VIA Pharmaceuticals, Inc. | c98548exv32w1.htm |
EX-31.1 - EXHIBIT 31.1 - VIA Pharmaceuticals, Inc. | c98548exv31w1.htm |
EX-21.1 - EXHIBIT 21.1 - VIA Pharmaceuticals, Inc. | c98548exv21w1.htm |
EX-32.2 - EXHIBIT 32.2 - VIA Pharmaceuticals, Inc. | c98548exv32w2.htm |
EX-31.2 - EXHIBIT 31.2 - VIA Pharmaceuticals, Inc. | c98548exv31w2.htm |
EX-10.2 - EXHIBIT 10.2 - VIA Pharmaceuticals, Inc. | c98548exv10w2.htm |
EX-10.12 - EXHIBIT 10.12 - VIA Pharmaceuticals, Inc. | c98548exv10w12.htm |
EX-10.11 - EXHIBIT 10.11 - VIA Pharmaceuticals, Inc. | c98548exv10w11.htm |
EXHIBIT
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to
the incorporation by reference in Registration Statement No. 333-158276, No. 333 149988,
No. 333 145505, 333-148075, 333-134383, 333-117945, and 333-108314 on Form S-8 and Registration
Statement No. 333-145504 on Form S-3, of our report dated March 30, 2010, relating to the
financial statements of VIA Pharmaceuticals, Inc., (which report expresses an unqualified opinion
and includes an explanatory paragraph relating to going concern uncertainty) appearing in this
Annual Report on Form 10-K of VIA Pharmaceuticals, Inc. for the year
ended December 31, 2009.
/s/
Deloitte & Touche LLP
San
Francisco, California
March 30, 2010
March 30, 2010